PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.\', \'Department of Urology, Austin Health, Heidelberg, Victoria, Australia.\', \'Australian and New Zealand Intensive Care-Research Centre, Monash University, Melbourne, Victoria, Australia.\', \'Centre for Integrated Critical Care, The University of Melbourne, Parkville, Victoria, Australia.\', \'Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.\', \'Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.\', \'Department of Infectious Disease, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jmv.26895
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 33629384
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
?:title
  • A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all